US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US5443841A
(en)
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US6331318B1
(en)
*
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5629020A
(en)
*
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5352461A
(en)
*
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
US6916489B2
(en)
*
|
1992-06-15 |
2005-07-12 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5401516A
(en)
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US6610329B2
(en)
|
1993-04-22 |
2003-08-26 |
Emisphere Technologies Inc. |
Compositions for the delivery of antigens
|
US20010003001A1
(en)
|
1993-04-22 |
2001-06-07 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5766633A
(en)
|
1993-04-22 |
1998-06-16 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5466259A
(en)
*
|
1994-03-07 |
1995-11-14 |
Durette; Jean-Francois |
Orbital implant and method
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
PL320856A1
(en)
|
1994-12-22 |
1997-11-10 |
Astra Ab |
Aerosol drug preparations
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
BR9604880A
(pt)
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US6428771B1
(en)
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5667806A
(en)
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US5824345A
(en)
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
WO1997010197A1
(en)
|
1995-09-11 |
1997-03-20 |
Emisphere Technologies, Inc. |
METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES
|
JP2000500461A
(ja)
*
|
1995-11-13 |
2000-01-18 |
スミスクライン・ビーチャム・コーポレイション |
血液調節化合物
|
AU2595697A
(en)
|
1996-03-29 |
1997-10-22 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
WO1997047288A1
(en)
|
1996-06-14 |
1997-12-18 |
Emisphere Technologies, Inc. |
Microencapsulated fragrances and method for preparation
|
CA2243643A1
(en)
|
1996-11-18 |
1998-05-28 |
Susan Haas |
Methods and compositions for inducing oral tolerance in mammals
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
US5891237A
(en)
*
|
1997-10-08 |
1999-04-06 |
Millennium Inorganic Chemicals, Ltd. |
Production of free flowing spheres using partially neutralized fatty acid
|
HUP0103318A2
(hu)
|
1998-07-27 |
2002-01-28 |
Emisphere Technologies Inc. |
Eljárás hatóanyagok bevitelére tüdőn keresztül
|
US6440929B1
(en)
|
1998-07-27 |
2002-08-27 |
Emisphere Technologies, Inc. |
Pulmonary delivery of active agents
|
US6991798B1
(en)
|
1998-08-07 |
2006-01-31 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
EP1102742B1
(de)
*
|
1998-08-07 |
2006-06-14 |
Emisphere Technologies, Inc. |
Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
|
NZ512581A
(en)
|
1999-01-08 |
2002-12-20 |
Univ Virginia Commonwealth |
Polymeric delivery agents comprising a polymer conjugated to a modified amino acid and derivatives thereof
|
JP2002537343A
(ja)
*
|
1999-02-23 |
2002-11-05 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
多重粒子製剤
|
CA2364849A1
(en)
|
1999-02-26 |
2000-08-31 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
ATE288415T1
(de)
|
1999-04-05 |
2005-02-15 |
Emisphere Tech Inc |
Dinatrium-salze, monohydrate und ethanol-solvate
|
AU2012201760B2
(en)
*
|
1999-06-29 |
2015-04-16 |
Mannkind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
JP4713798B2
(ja)
*
|
1999-06-29 |
2011-06-29 |
マンカインド コーポレイション |
ペプチドおよびタンパク質の薬学的因子の精製および安定化
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7279597B1
(en)
|
1999-11-05 |
2007-10-09 |
Emisphere Technologies, Inc. |
Phenyl amine carboxylic acid compounds and compositions for delivering active agents
|
US7129274B1
(en)
|
1999-11-05 |
2006-10-31 |
Emisphere Technologies Inc. |
Phenoxy carboxylic acid compounds and compositions for delivering active agents
|
AU4304901A
(en)
|
1999-11-15 |
2001-06-04 |
Biocure, Inc. |
Responsive polymeric hollow particles
|
DE60038183T2
(de)
|
1999-12-16 |
2009-02-19 |
Emisphere Technologies, Inc. |
Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
|
WO2001052818A1
(en)
*
|
2000-01-19 |
2001-07-26 |
Pharmaceutical Discovery Corporation |
Dry powder formulations of antihistamine for nasal administration
|
US6808707B2
(en)
|
2000-02-04 |
2004-10-26 |
Matrix Design |
Wound healing compositions and methods using tropoelastin and lysyl oxidase
|
DE10019879A1
(de)
*
|
2000-04-20 |
2001-10-25 |
Degussa |
Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
|
US6537968B1
(en)
*
|
2000-07-24 |
2003-03-25 |
Alphamed Pharmaceuticals Corp |
Treatment of lupus erythematosus
|
AU7931301A
(en)
|
2000-08-04 |
2002-02-18 |
Dmi Biosciences Inc |
Method of using diketopiperazines and composition containing them
|
AU2001297611A1
(en)
*
|
2000-12-29 |
2002-08-19 |
Celltech R And D, Inc. |
Pharmaceutical uses and synthesis of diketopiperazines
|
US20030225300A1
(en)
*
|
2001-04-19 |
2003-12-04 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
WO2003061578A2
(en)
*
|
2002-01-18 |
2003-07-31 |
Mannkind Corporation |
Compositions for treatment or prevention of bioterrorism
|
EP1494732B1
(de)
*
|
2002-03-20 |
2008-01-30 |
MannKind Corporation |
Inhalationsgerät
|
US7053034B2
(en)
*
|
2002-04-10 |
2006-05-30 |
Salvona, Llc |
Targeted controlled delivery compositions activated by changes in pH or salt concentration
|
WO2003090693A2
(en)
*
|
2002-04-23 |
2003-11-06 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical composition containing lamotrigine particles of defined morphology
|
US20040028729A1
(en)
*
|
2002-04-29 |
2004-02-12 |
Shojaei Amir H. |
Pharmaceutical formulations with improved bioavailability
|
AU2003257156B2
(en)
|
2002-08-01 |
2007-08-30 |
Mannkind Corporation |
Cell transport compositions and uses thereof
|
US20080260838A1
(en)
*
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
US20040038865A1
(en)
*
|
2002-08-01 |
2004-02-26 |
Mannkind Corporation |
Cell transport compositions and uses thereof
|
US20040171518A1
(en)
*
|
2003-02-27 |
2004-09-02 |
Medtronic Minimed, Inc. |
Compounds for protein stabilization and methods for their use
|
US20040224024A1
(en)
*
|
2003-04-23 |
2004-11-11 |
Massachusetts Institute Of Technology |
Controlled drug release formulations containing polyion complexes
|
CA3050734A1
(en)
|
2003-05-15 |
2004-12-02 |
Ampio Pharmaceuticals, Inc. |
Treatment of t-cell mediated diseases
|
KR20060054371A
(ko)
*
|
2003-07-31 |
2006-05-22 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
캡슐화 및 제어된 방출을 위한 조성물
|
US8921311B2
(en)
|
2003-08-01 |
2014-12-30 |
Mannkind Corporation |
Method for treating hyperglycemia
|
AU2004316165B2
(en)
*
|
2003-09-23 |
2009-03-05 |
Wisconsin Alumni Research Foundation |
Using liquid crystals to detect affinity microcontact printed biomolecules
|
US7795007B2
(en)
|
2003-09-23 |
2010-09-14 |
Wisconsin Alumni Research Foundation |
Detection of post-translationally modified peptides with liquid crystals
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
ES2584867T3
(es)
*
|
2004-01-12 |
2016-09-29 |
Mannkind Corporation |
Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2
|
US20070027063A1
(en)
*
|
2004-01-12 |
2007-02-01 |
Mannkind Corporation |
Method of preserving the function of insulin-producing cells
|
JP2005209106A
(ja)
*
|
2004-01-26 |
2005-08-04 |
Nec Corp |
携帯通信端末、受信メール管理方法、プログラムおよび記録媒体
|
ATE433746T1
(de)
*
|
2004-03-12 |
2009-07-15 |
Biodel Inc |
Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
KR101273120B1
(ko)
*
|
2004-08-20 |
2013-06-13 |
맨카인드 코포레이션 |
다이케토피페라진 합성의 촉매 작용
|
KR20130066695A
(ko)
|
2004-08-23 |
2013-06-20 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
CN101014321A
(zh)
*
|
2004-08-23 |
2007-08-08 |
曼金德公司 |
5型磷酸二酯酶抑制剂的肺部给予
|
US20060153778A1
(en)
*
|
2005-01-10 |
2006-07-13 |
Mannkind Corporation |
Methods and compositions for minimizing accrual of inhalable insulin in the lungs
|
CA2611944A1
(en)
|
2005-06-15 |
2006-12-28 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
US20070004036A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for keratinocyte culture
|
US20070128685A1
(en)
*
|
2005-07-01 |
2007-06-07 |
Rodolfo Faudoa |
Methods and compositions for cell culture
|
US20070003541A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for therapeutics
|
IN2014DN09128A
(de)
*
|
2005-09-14 |
2015-07-10 |
Mannkind Corp |
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
MX339072B
(es)
*
|
2005-11-21 |
2016-05-09 |
Mannkind Corp |
Aparato y metodos para suministrar y detectar polvo.
|
BRPI0707991B8
(pt)
|
2006-02-22 |
2021-05-25 |
Mannkind Corp |
métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
|
JP2009533471A
(ja)
|
2006-04-12 |
2009-09-17 |
バイオデル, インコーポレイテッド |
即効型および長時間作用型組合せインスリン製剤
|
JP5415938B2
(ja)
*
|
2006-04-14 |
2014-02-12 |
マンカインド コーポレイション |
グルカゴン様ペプチド1(glp−1)医薬製剤
|
AU2007280995C1
(en)
*
|
2006-08-04 |
2013-05-23 |
Manus Pharmaceuticals (Canada) Ltd. |
Multifunctional bioactive compounds
|
ATE475686T1
(de)
|
2006-10-31 |
2010-08-15 |
Surmodics Pharmaceuticals Inc |
Kugelförmige polymer-teilchen
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
BRPI0818872A2
(pt)
|
2007-10-24 |
2015-05-05 |
Mannkind Corp |
Método para prevenir efeitos adversos por glp-1
|
CA2703234C
(en)
*
|
2007-10-24 |
2021-10-26 |
Mannkind Corporation |
An inhalable dry powder formulation comprising glp-1 for use by pulmonary inhalation
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
US8217047B2
(en)
*
|
2008-05-27 |
2012-07-10 |
Dmi Acquisition Corp. |
Therapeutic methods and compounds
|
CN109568740B
(zh)
|
2008-06-13 |
2022-05-27 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
US8485180B2
(en)
*
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
ES2904623T3
(es)
|
2008-06-20 |
2022-04-05 |
Mannkind Corp |
Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
|
CN102143890B
(zh)
|
2008-08-05 |
2013-08-28 |
曼康公司 |
改进的粉末分配器模块及粉末分配器组件
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
US8969353B2
(en)
|
2008-11-07 |
2015-03-03 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
MX2011007065A
(es)
|
2008-12-29 |
2011-08-03 |
Mannkind Corp |
Analogos de dicetopiperazina substituida para usarse como agentes de suministro de farmaco.
|
ES2529100T3
(es)
|
2009-01-08 |
2015-02-16 |
Mannkind Corporation |
Tratamiento de la hiperglucemia con GLP-1
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
CA2791847C
(en)
*
|
2009-03-04 |
2017-05-02 |
Mannkind Corporation |
An improved dry powder drug delivery system
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
SG176778A1
(en)
*
|
2009-06-12 |
2012-01-30 |
Mannkind Corp |
Diketopiperazine microparticles with defined isomer contents
|
KR101875969B1
(ko)
|
2009-06-12 |
2018-07-06 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
US8642548B2
(en)
|
2009-08-07 |
2014-02-04 |
Mannkind Corporation |
Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
|
BR112012011591B1
(pt)
|
2009-11-02 |
2020-02-27 |
Mannkind Corporation |
Reator, sistema e método voltado para a produção de partículas em um processo de precipitação
|
CN102596238B
(zh)
|
2009-11-02 |
2014-06-18 |
曼康公司 |
用于对药物组合物进行低温造粒的装置和方法
|
EP2496295A1
(de)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
|
ES2734973T3
(es)
|
2009-12-01 |
2019-12-13 |
Translate Bio Inc |
Administración de ARNm para el aumento de proteínas y enzimas en enfermedades genéticas humanas
|
WO2011140175A1
(en)
|
2010-05-07 |
2011-11-10 |
Mannkind Corporation |
Determining percent solids in suspension using raman spectroscopy
|
KR20130117755A
(ko)
|
2010-06-21 |
2013-10-28 |
맨카인드 코포레이션 |
건조 분말 약물 운반 시스템 및 방법
|
EP2609135A4
(de)
|
2010-08-26 |
2015-05-20 |
Massachusetts Inst Technology |
Poly(beta-amino-alkohole), ihre herstellung und verwendungen davon
|
WO2012033792A2
(en)
|
2010-09-07 |
2012-03-15 |
Dmi Acquisition Corp. |
Treatment of diseases
|
WO2012064892A1
(en)
|
2010-11-09 |
2012-05-18 |
Mannkind Corporation |
Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
|
RU2606624C2
(ru)
|
2011-02-10 |
2017-01-10 |
Маннкайнд, Корп |
Получение n-защищенного бис-3,6-(4-аминоалкил)-2,5-дикетопиперазина
|
PL2691443T3
(pl)
|
2011-03-28 |
2021-08-30 |
Massachusetts Institute Of Technology |
Sprzężone lipomery i ich zastosowania
|
JP6133270B2
(ja)
|
2011-04-01 |
2017-05-24 |
マンカインド コーポレイション |
薬剤カートリッジのためのブリスター包装
|
ES2711670T3
(es)
|
2011-04-12 |
2019-05-06 |
Moerae Matrix Inc |
Composiciones y métodos para la prevención o tratamiento de la fibrosis pulmonar
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
WO2012170547A1
(en)
*
|
2011-06-06 |
2012-12-13 |
Perosphere, Inc. |
Bioadhesive drug delivery compositions
|
EP2717893B1
(de)
|
2011-06-08 |
2019-05-08 |
Translate Bio, Inc. |
Lipidnanoteilchenzusammensetzungen und verfahren zur mrna-freisetzung
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
US8980834B2
(en)
|
2011-10-10 |
2015-03-17 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
KR20140075772A
(ko)
|
2011-10-10 |
2014-06-19 |
앰피오 파마슈티컬스 인코퍼레이티드 |
면역 내성을 증가시킨 이식 의료 장비, 및 그의 제조 및 이식 방법
|
BR112014009686A2
(pt)
|
2011-10-24 |
2018-08-07 |
Mannkind Corp |
composição analgésica inalável, pó seco e método para tratar dor
|
EA032088B1
(ru)
|
2011-10-27 |
2019-04-30 |
Массачусетс Инститьют Оф Текнолоджи |
Аминокислотные производные, функционализованные на n-конце, способные образовывать микросферы, инкапсулирующие лекарственное средство
|
SG11201400283RA
(en)
|
2011-10-28 |
2014-03-28 |
Ampio Pharmaceuticals Inc |
Treatment of rhinitis
|
WO2013114371A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dry powder formulations of dnase i
|
RS57845B1
(sr)
|
2012-02-09 |
2018-12-31 |
Novus Int Inc |
Ciklični dimeri koji sadrže heteroatom
|
WO2013142969A1
(en)
*
|
2012-03-28 |
2013-10-03 |
Jian Ping Gao |
Urethanes and ureas and processes
|
MX361470B
(es)
|
2012-04-27 |
2018-12-06 |
Mannkind Corp |
Métodos para la síntesis de etilfumaratos y su uso como intermediarios.
|
WO2013185067A1
(en)
|
2012-06-08 |
2013-12-12 |
Shire Human Genetic Therapies, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
AU2013289957B2
(en)
|
2012-07-12 |
2017-02-23 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
CN107753462B
(zh)
|
2012-07-12 |
2021-01-08 |
诺华丝国际股份有限公司 |
用于保护生物活性剂的基质和层组合物
|
CA2884870C
(en)
|
2012-08-13 |
2022-03-29 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
EP2911690A1
(de)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalierbare influenza-impfstoffzusammensetzungen und verfahren
|
EP3467108B1
(de)
|
2013-03-14 |
2024-05-22 |
Translate Bio, Inc. |
Verfahren zur reinigung von messenger-rna
|
IL290953B2
(en)
|
2013-03-14 |
2024-01-01 |
Ethris Gmbh |
CFTR mRNA Assemblies and Related Methods and Uses
|
ES2754388T3
(es)
|
2013-03-15 |
2020-04-17 |
Mannkind Corp |
Composiciones y métodos de dicetopiperazina microcristalina
|
MX2015010937A
(es)
|
2013-03-15 |
2015-10-29 |
Ampio Pharmaceuticals Inc |
Composiciones para la movilizacion, autodireccion, expansion y diferenciacion de celulas madre y metodos para usar las mismas.
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
BR122019026637B1
(pt)
|
2013-07-18 |
2023-09-26 |
Mannkind Corporation |
Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
EP3060257B1
(de)
|
2013-10-22 |
2021-02-24 |
Translate Bio, Inc. |
Lipidzusammensetzungen zur verabreichung von mrna
|
EP3060258A1
(de)
|
2013-10-22 |
2016-08-31 |
Shire Human Genetic Therapies, Inc. |
Mrna-therapie für phenylketonurie
|
MX2016005237A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Terapia de acido ribonucleico mensajero para la deficiencia de argininosuccinato sintetasa.
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
CN117402871A
(zh)
|
2014-04-25 |
2024-01-16 |
川斯勒佰尔公司 |
信使rna的纯化方法
|
EP3148552B1
(de)
*
|
2014-05-30 |
2019-07-31 |
Translate Bio, Inc. |
Biologisch abbaubare lipide zur freisetzung von nukleinsäuren
|
NZ727281A
(en)
|
2014-06-24 |
2024-02-23 |
Translate Bio Inc |
Stereochemically enriched compositions for delivery of nucleic acids
|
EP3164379A1
(de)
|
2014-07-02 |
2017-05-10 |
Massachusetts Institute of Technology |
Lipidoide aus polyaminfettsäure und verwendungen davon
|
JP6723222B2
(ja)
|
2014-08-18 |
2020-07-15 |
アンピオ ファーマシューティカルズ,インコーポレイテッド |
関節病態の治療
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
CN107106650A
(zh)
|
2014-11-17 |
2017-08-29 |
莫伊莱麦屈克斯公司 |
用于预防或治疗表征为异常的成纤维细胞增殖和细胞外基质沉积的疾病、状况或过程的组合物和方法
|
RU2017135072A
(ru)
|
2015-03-12 |
2019-04-10 |
Мори Матрикс, Инк. |
Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого
|
CN104961687B
(zh)
*
|
2015-06-03 |
2017-07-25 |
苏州维泰生物技术有限公司 |
1,2‑二嗪衍生物及其制剂、用途
|
EP3310764B1
(de)
|
2015-06-19 |
2023-04-19 |
Massachusetts Institute of Technology |
Alkenyl substituierte 2,5-piperazindione und ihre verwendung in zusammensetzungen zur verabreichung eines mittels an eine person oder in eine zelle
|
WO2016209969A1
(en)
|
2015-06-22 |
2016-12-29 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
WO2017132601A1
(en)
*
|
2016-01-29 |
2017-08-03 |
Mannkind Corporation |
Dry powder inhaler
|
TW201809049A
(zh)
|
2016-03-31 |
2018-03-16 |
盧伯利索先進材料有限公司 |
生物可分解及/或生物可吸收的熱塑性聚胺甲酸酯
|
EA201991747A1
(ru)
|
2017-02-27 |
2020-06-04 |
Транслейт Био, Инк. |
НОВАЯ КОДОН-ОПТИМИЗИРОВАННАЯ мРНК CFTR
|
CA3063531A1
(en)
|
2017-05-16 |
2018-11-22 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
US20200230066A1
(en)
*
|
2017-10-06 |
2020-07-23 |
The Regents Of The University Of California |
Self-Assembled Microcapsules for Optically Controlled Cargo Encapsulation and Release
|
JP2021527058A
(ja)
*
|
2018-06-07 |
2021-10-11 |
マンカインド コーポレイション |
吸入のための組成物および方法
|
US11174500B2
(en)
|
2018-08-24 |
2021-11-16 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|